McLintock Cameron A, McKelvie James, Gatzioufas Zisis, Wilson Jessica J, Stephensen David C, Apel Andrew J G
Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, Brisbane, QLD, 4102, Australia.
Queen Victoria Hospital, Holtye Road, East Grinstead, RH19 3DZ, UK.
Int Ophthalmol. 2019 Sep;39(9):1965-1972. doi: 10.1007/s10792-018-1027-7. Epub 2018 Oct 29.
To evaluate rotational stability and visual and refractive outcomes of supplementary toric IOLs (Sulcoflex Toric 653T, Rayner Intraocular Lenses Ltd) for residual astigmatic refractive error in pseudophakic eyes.
A retrospective interventional case series was conducted in a single surgeon practice. Charts of patients who had Sulcoflex Toric supplementary IOLs inserted between June 2009 and September 2015 were reviewed. Outcomes were compared between eyes with and without prior corneal transplant. Patients with at least 3-months follow-up were included.
In 51 eyes, mean UDVA improved from 20/86 to 20/43 (p = 0.002), though UDVA was better in eyes without corneal grafts (20/31) than eyes with (20/62). The proportion of eyes achieving 20/20 UDVA was 43%, 61% and 17% overall, in eyes with prior graft and in eyes with no prior graft, respectively. Sixty-four percentage achieved a spherical equivalent of within 0.5D of target (84% no graft, 34% prior graft). Fifty-three percentage of eyes achieved a cylinder of within 0.5D of target (no graft: 73%, prior graft: 0%). Mean lens rotation was 8.23° on day 1, and mean maximal rotation during follow-up was 17.63°. Sixty-two percentage of IOLs required repositioning. Of those that required repositioning, this was conducted a mean of 2.3 times. The mean final IOL rotation (following repositioning if required) was 6.17°.
Sulcoflex Toric supplementary IOLs result in good visual and refractive outcomes in eyes with no prior corneal graft. However, outcomes are sub-optimal in eyes with prior corneal transplantation, and the majority of lenses require repositioning.
评估补充型环曲面人工晶状体(Sulcoflex Toric 653T,Rayner人工晶状体有限公司)用于矫正假晶状体眼残余散光屈光不正的旋转稳定性以及视觉和屈光效果。
在一位外科医生的临床实践中进行了一项回顾性干预病例系列研究。回顾了2009年6月至2015年9月期间植入Sulcoflex Toric补充型人工晶状体的患者病历。比较了有和没有角膜移植史的患者的手术效果。纳入了至少随访3个月的患者。
在51只眼中,平均未矫正远视力(UDVA)从20/86提高到了20/43(p = 0.002),不过没有角膜移植的眼(20/31)的UDVA比有角膜移植的眼(20/62)更好。总体上、有既往移植史的眼和无既往移植史的眼中,达到20/20 UDVA的眼的比例分别为43%、61%和17%。64%的眼达到了等效球镜度在目标值0.5D以内(无移植史的眼为84%,有既往移植史的眼为34%)。53%的眼达到了柱镜度在目标值0.5D以内(无移植史的眼:73%,有既往移植史的眼:0%)。术后第1天人工晶状体平均旋转角度为8.23°,随访期间平均最大旋转角度为17.63°。62%的人工晶状体需要重新定位。在那些需要重新定位的人工晶状体中,平均重新定位次数为2.3次。最终人工晶状体平均旋转角度(如有需要,重新定位后)为6.17°。
Sulcoflex Toric补充型人工晶状体在没有角膜移植史的眼中可带来良好的视觉和屈光效果。然而,在有角膜移植史的眼中,手术效果欠佳,并且大多数人工晶状体需要重新定位。